SCHEMBL3107262

SCHEMBL3107262

CONC(=O)c1ccc(C)c(-n2cnc3ccc(OCCCl)cc3c2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.50
MMP13 P45452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3103648 0.91 MAPK14 (0.51) MAPK14
SCHEMBL3121346 0.89 MAPK14 (0.49) MAPK14
SCHEMBL3105870 0.89 MAPK14 (0.63) MAPK14MMP13
SCHEMBL3118662 0.88 MAPK14 (0.51) MAPK14
SCHEMBL3110329 0.88 MAPK14 (0.49) MAPK14MMP13
SCHEMBL1140091 0.88 MAPK14 (0.65) MAPK14
SCHEMBL3108389 0.87 MAPK14 (0.55) MAPK14
SCHEMBL3114262 0.86 MAPK14 (0.46) MAPK14
SCHEMBL3117449 0.86 MAPK14 (0.50) MAPK14
SCHEMBL3104987 0.86 MAPK14 (0.58) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256120-A1 AMIDE DERIVATIVES ASTRAZENECA AB 2010-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256120-A1 AMIDE DERIVATIVES IL1B, IL1A, IL6 MAPK14 2363/4885MMP13 1801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.